The Ebola emergency--immediate action, ongoing strategy. by Farrar, Jeremy J & Piot, Peter
Farrar, JJ; Piot, P (2014) The Ebola Emergency - Immediate Action,
Ongoing Strategy. The New England journal of medicine, 371 (16).
pp. 1545-6. ISSN 0028-4793 DOI: 10.1056/NEJMe1411471
Downloaded from: http://researchonline.lshtm.ac.uk/1947014/
DOI: 10.1056/NEJMe1411471
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Copyright the publishers
n engl j med 371;16 nejm.org october 16, 2014 1545
e d i t o r i a l
T h e  n e w  e ngl a nd  j o u r na l  o f  m e dic i n e
The Ebola Emergency — Immediate Action, Ongoing Strategy
Jeremy J. Farrar, M.D., Ph.D., and Peter Piot, M.D., Ph.D.
The 25th known outbreak of Ebola virus infec-
tion is unlike any of the previous epidemics. It 
has already killed over 2800 people — more than 
all previous epidemics combined; it’s affecting 
virtually the entire territory of three countries, 
involving rural areas, major urban centers, and 
capital cities; it has been going on for almost a 
year; and it is occurring in West Africa, where no 
Ebola outbreak had previously occurred. Above 
all, the epidemic seems out of control and has 
evolved into a major humanitarian crisis that 
has finally mobilized the world, with responses 
ranging from an emergency health mission 
launched by the United Nations Security Council 
to proposed military-style interventions and the 
global provision of emergency aid.
The disintegration of the health care systems 
in the affected countries is already having a pro-
found impact on the populations’ health beyond 
Ebola, as clinics close or become overwhelmed or 
nonfunctional. These health system effects will 
only worsen as the epidemic progresses: West 
Africa will see much more suffering and many 
more deaths during childbirth and from malaria, 
tuberculosis, HIV–AIDS, enteric and respiratory 
illnesses, diabetes, cancer, cardiovascular dis-
ease, and mental health during and after the 
Ebola epidemic. Indeed, there is a very real dan-
ger of a complete breakdown in civic society, as 
desperate communities understandably lose faith 
in the established systems.
A report from the Ebola Response Team of 
the World Health Organization now published 
in the Journal presents the first comprehensive 
analysis of epidemiologic surveillance data on 
the West African epidemic.1 Though the com-
pleteness and quality of the data are uncertain 
— collecting information under such extreme 
conditions is an enormous challenge, and the 
remarkable contribution of the data-collection 
teams in West Africa must be acknowledged — 
they provide a convincing case that the epidemic 
is still expanding, with a conservative projection 
that there will be close to 20,000 cases by early 
November. Without a more effective, all-out effort, 
Ebola could become endemic in West Africa, 
which could, in turn, become a reservoir for the 
virus’s spread to other parts of Africa and beyond.
Yet despite the vast scale of the current out-
break, the clinical manifestations of Ebola virus 
disease, the duration of illness, the case fatality 
rate, and the degree of transmissibility are simi-
lar to those in earlier epidemics. It is therefore 
unlikely that the particularly devastating course 
of this epidemic can be attributed to biologic 
characteristics of the virus. It is more likely to 
be a result of the combination of dysfunctional 
health systems, international indifference, high 
population mobility, local customs, densely pop-
ulated capitals, and lack of trust in authorities 
after years of armed conflict. Perhaps most im-
portant, Ebola has reached the point where it 
could establish itself as an endemic infection be-
cause of a highly inadequate and late global re-
sponse. Not only did it take more than 3 months 
to diagnose Ebola as the cause of the epidemic 
(in contrast to the recent outbreak in the Demo-
cratic Republic of Congo, where it took a matter 
of days), but it was not until 5 months and 1000 
deaths later that a public health emergency was 
declared, and it was nearly another 2 months 
before a humanitarian response began to be put 
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in place. It is not that the world did not know: 
Médicins sans Frontières, which has been spear-
heading the response and care for patients with 
Ebola, has been advocating for a far greater re-
sponse for many months. This epidemic, in other 
words, was an avoidable crisis, and as the Ebola 
Response Team’s article stresses, a prompt re-
sponse to an emerging outbreak is critical in 
order to contain it before it becomes too vast in 
terms of both numbers of cases and geographic 
reach.
The current Ebola epidemic highlights three 
transformations required in our approach to rap-
idly emerging public health emergencies.
First, in today’s world, it’s important to rec-
ognize that if certain conditions are met — bio-
logic shifts in a pathogen, changes in the inter-
actions between humans and our environment, 
dysfunctional and underresourced health sys-
tems, national and international indifference, 
lack of effective timely response, high popula-
tion mobility, local customs that can exacerbate 
morbidity and mortality, spread in densely pop-
ulated urban centers, and a lack of trust in au-
thorities — what might once have been a limited 
outbreak can become a massive, nearly uncon-
trollable epidemic.
Second, classic “outbreak control” efforts are 
no longer sufficient for an epidemic of this size. 
Rather, what’s required is a large-scale, coordi-
nated humanitarian, social, public health, and 
medical response, combining classic public 
health measures with safe and effective inter-
ventions including behavioral changes, therapies, 
and when possible, vaccination. An appropriate 
response, moreover, requires an appreciation of 
the culture of the societies in the affected coun-
tries and deployment of interventions with the 
population’s consent. Development of interven-
tions in collaboration with the affected commu-
nities and rebuilding of trust will be essential to 
their success. And these integrated efforts will 
need to be accompanied by much better coordi-
nation and real-time, open sharing of informa-
tion across diverse disciplines and with all the 
players involved, from civil society, national gov-
ernments, nongovernmental organizations, and 
academic institutions to regional and international 
organizations and, when appropriate, the military.
Third, the development of diagnostic tools, 
therapies, and vaccines (at least up through the ac-
quisition of phase 1 safety data) for these relatively 
rare but inevitable and potentially devastating 
epidemic diseases must be prioritized during in-
terepidemic periods, with an accepted, preap-
proved, and ethical mechanism for accelerating 
development and testing such interventions when 
epidemic situations arise. We believe that in this 
epidemic, we are reaching the limit of what 
classic containment can achieve.
Meanwhile, the current Ebola epidemic, which 
is in grave danger of spiraling out of control, 
must remain the primary focus of our efforts. We 
are concerned that without a massive increase in 
the response, way beyond what is being planned 
in scale and urgency, alongside the complementa-
ry deployment of novel interventions (in particular 
the use of safe and effective vaccines and thera-
peutics), it will prove impossible to bring this 
epidemic under control.
But we must also look to the future. There will 
be more epidemics and outbreaks of Ebola and 
other new or reemerging infections. Yet our re-
sponse to such events remains slow, cumbersome, 
poorly funded, conservative, and ill prepared. We 
have been very lucky with the severe acute respi-
ratory syndrome (SARS), H5N1 and H1N1 influ-
enza, and possibly the Middle East respiratory syn-
drome coronavirus (MERS-CoV), but this Ebola 
epidemic shows what can happen when luck es-
capes us. With a different pathogen and a differ-
ent transmission route, a similar crisis could 
strike in New York, Geneva, and Beijing as easily 
as this one has in West Africa.
Despite great improvement over the past dec-
ade, there is still a need for better surveillance, 
sharing of data in real time, and rapid action 
based on the available information. But we can-
not think that surveillance alone will bring such 
events under control. We have become better at 
picking these things up; we now must also learn 
to act more effectively.
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